Response to superantigens in HIV-1 and HIV-2 infected nonhuman primates. NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Response to superantigens in HIV-1 and HIV-2 infected nonhuman primates.

Symp Nonhum Primate Models AIDS. 1992 Nov 17-20;10:abstract no. 102. Unique Identifier : AIDSLINE PRIM10/93200948
Murthy KK; Guevara SM; Department of Virology and Immunology, Southwest Foundation for; Biomedical Research, San Antonio, TX 78228.


Abstract: Superantigens are bacterial endotoxins that act as potent stimulators of T cells from mice and man. According to recent studies, proliferative response to superantigens is depressed in HIV-1 infected humans, presumably due to deletion of T cell clones mediated by viral infection. Therefore, we evaluated the response of chimpanzees, baboons, and macaques to superantigens and, in addition, studied the effect of infection with HIV-1 and HIV-2 in chimpanzees and baboons, respectively. Heparinized blood samples were collected from seven healthy chimpanzees, ten baboons, and six human donors, as well as from seven chimpanzees infected with HIV-1, and five baboons infected with HIV-2. Peripheral blood lymphocytes (PBL's) were cultured for 72 hr with various concentrations of S. aureus enterotoxins (SE) A, B, and C. Cultures were pulsed with H-thymidine and cells were harvested to quantitate the level of T cell proliferation induced by SEA, SEB, and SEC. All three toxins induced significant proliferation of T cells, from all of the species tested, in a dose dependent manner. No marked differences in cell stimulatory function were evident among the three SE in the chimpanzees. Similar observations were made in baboons regardless of their infection status. The response in HIV-1 infected chimpanzees was significantly lower (p < 0.05) than in the uninfected group. There was significant difference in proliferative responses to SEA, SEB, and SEC between chimpanzees and baboons, further, human T cells had significantly higher responses (p < 0.001 to 0.05) to all three SE, compared to chimpanzee or baboon T cells. In conclusion, there appear to be species differences between humans and nonhuman primates in their ability to respond to superantigens, and furthermore, infection with HIV-1 appears to impair the proliferative response of T cells from nonhuman primates.
Keywords: Acquired Immunodeficiency Syndrome/*IMMUNOLOGY Animal Cells, Cultured Chimpansee troglodytes Enterotoxins/*PHARMACOLOGY Human *HIV-1 *HIV-2 *Lymphocyte Transformation Papio *Staphylococcus aureus T-Lymphocytes/DRUG EFFECTS/*IMMUNOLOGY ABSTRACTKWDacquiredimmunodeficiencysyndrome/KWDimmunologyanimalcells,culturedchimpanseetroglodytesenterotoxins/KWDpharmacologyhumanKWDhiv-1KWDhiv-2KWDlymphocytetransformationpapioKWDstaphylococcusaureust-lymphocytes/drugeffects/KWDimmunologyabstract
930630
M9361072

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .